Adjuvant Immunotherapy Should Not be Used in Patients With a Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy

J Thorac Oncol. 2025 Jan;20(1):30-33. doi: 10.1016/j.jtho.2024.10.010.

Authors

William J Phillips¹, D Ross Camidge², Paul Wheatley-Price³

Affiliations

¹ Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado.
³ Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: [email protected].

PMID: 39794103
DOI: 10.1016/j.jtho.2024.10.010

No abstract available

Publication types

Editorial